The Translational Research Institute (TRI) brought together four of Australia’s pinnacle research facilities to improve and accelerate medical research and translate that research into greater patient care. The TRI allows, for the first time in Australia, biopharmaceuticals and treatments to be discovered, produced, clinically tested, and manufactured in one location.
The TRI is a joint venture between The University of Queensland Diamantina Institute, Queensland University of Technology’s Biomedical Innovation, Mater Medical Research Institute, and the Princess Alexandra Hospital’s Centres for Health Research.
The centre was the vision of world-renowned inventor of the cervical cancer vaccine and 2006 Australian of the Year, Professor Ian Frazer, and the Mater Medical Research Institute.
To discover more information, visit the Translational Research Institute website.